BioWorld

Aug. 26, 2003

Coley Raises $35M To Finance Pipeline In Cancer, Viral Disease

Coley Pharmaceutical Group Inc. secured $35 million in private financing to fund further development of its clinical pipeline. (BioWorld Today) Read More

Amgen Gains Broadened Label For Enbrel In Psoriatic Arthritis

Roswell Scientists Seek To Crack Incurable Deadly Syndrome By Plumbing Albino Mice Mutations

NewNeural Using Marrow Stem Cells For CNS Diseases, Injury

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.